Exagen Inc. to Participate in Upcoming Investor Conferences
Exagen Inc. (XGN)
Last exagen inc. earnings: 3/25 04:05 pm
Check Earnings Report
Company Research
Source: GlobeNewswire
CARLSBAD, Calif., March 03, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced that management will participate in the following investor conferences: KeyBank Capital Markets Healthcare Forum - Virtual Date: March 17, 2026 Participation: Investor meetings and fireside chat at 3:00 p.m. ET Roth Capital Conference – Laguna Niguel, CA Date: March 23, 2026 Participation: Investor meetings About Exagen Inc. Exagen Inc. (Nasdaq: XGN) is a leading provider of autoimmune diagnostics, committed to transforming care for patients with chronic and debilitating autoimmune conditions. Based in San Diego County, California, Exagen’s mission is to provide clarity in autoimmune disease decision-making and improve clinical outcomes through its innovative testing portfolio. The company’s flagship product, AVISE® CTD, enables clinicians to more effectively diagnose complex autoimmune conditions such as lupus, rheumatoid arthritis, and S
Show less
Read more
Impact Snapshot
Event Time:
XGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XGN alerts
High impacting Exagen Inc. news events
Weekly update
A roundup of the hottest topics
XGN
News
- Exagen (NASDAQ:XGN) had its price target lowered by analysts at TD Cowen from $13.00 to $10.00. They now have a "buy" rating on the stock.MarketBeat
- Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026 [Yahoo! Finance]Yahoo! Finance
- Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026GlobeNewswire
- Exagen (NASDAQ:XGN) had its price target lowered by analysts at BTIG Research from $15.00 to $10.00. They now have a "buy" rating on the stock.MarketBeat
- Exagen (NASDAQ:XGN) had its "buy" rating reaffirmed by analysts at B. Riley. They now have a $8.00 price target on the stock, down previously from $18.00.MarketBeat
XGN
Earnings
- 11/4/25 - Miss
XGN
Sec Filings
- 2/25/26 - Form 4
- 2/25/26 - Form 4
- 2/17/26 - Form SCHEDULE
- XGN's page on the SEC website